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Abstract.  Human platelets participate in a  number of 
adhesive interactions,  including binding to exposed 
subendothelium after vascular injury, and platelet- 
platelet cohesion to form large aggregates.  Platelet 
membrane glycoproteins (GP) Ilb and IIIa constitute a 
receptor for fibrinogen that,  together with fibrinogen 
and calcium, is largely responsible for mediating the 
formation of the primary hemostatic plug.  Using 
highly specific polyclonal and monoclonal antibodies 
as probes, we could detect the presence of both of 
these glycoproteins in cultured human umbilical vein 
endothelial cells.  Western-blot analysis showed that the 
endothelial cell analogues were similar in size to their 
platelet counterparts,  and were present in cells that 
had been in culture for over 2  mo.  Metabolic labeling 
of endothelium with [35S]methionine demonstrated that 
both GPIIb and GPIIIa were actively synthesized in 
culture.  Using the technique of crossed immunoelec- 
trophoresis, evidence was obtained that the endothelial 
cell forms of GPHb and GPIIIa may exist complexed 
to one another after solubilization in Triton X-100.  The 
presence of GPllb-l/Ia analogues in cultured en- 
dothelial cells may provide an opportunity to examine 
the structure, function, and synthesis of these two 
membrane glycoproteins, as well as provide a  source 
of genetic material with which to begin detailed 
molecular genetic studies. 
H 
UMAN platelets are thought to become activated in 
vivo in response to damage of a nearby blood vessel 
wall. Agents such as ADP, collagen, thrombin, and 
epinephrine are either generated or exposed at the site of vas- 
cular injury, and transform the normally unreactive discoid 
platelets into highly interactive spherical bodies from which 
extend several long protruding filipodia. These transformed 
platelets are then able to participate in a  number of inter- 
esting adhesive interactions, including binding to exposed 
subendothelial fibers and cohesion with each other to form 
large platelet aggregates (for a review, see reference 6). Cen- 
tral to the role of platelet-subendothelial and platelet-plate- 
let interactions is  a  plasma  membrane calcium-dependent 
heterodimer  protein  complex composed  of glycoproteins 
(GPs)  1 Ilb and HIa. These two glycoproteins comprise the 
fibrinogen receptor that mediates platelet aggregation (1, 2, 
26), haqebeen found to associate with the cytoskeleton after 
platelet activation (25, 27), bind von W'fllebrand factor in the 
absence of competing fibrinogen (29,  30),  and also carry 
several alloantigenic determinants that are the target of both 
allo- and auto-immune immunologic disorders (B, 24, 35). 
Although GPHb-IlIa has been thought to be platelet-specific, 
recent work in several laboratories indicates that structurally 
similar,  antigenically cross-reactive proteins may be found 
1. Abbreviations used in this paper: CIE, crossed  immunoelectrophoresis; 
EC, endothelial  cell; GP, glycoprotein. 
on other cell types, including human erythroleukemia cell 
lines (7, 32) and avian thrombocytes (15), as well. In particu- 
lar, Thiagarajan et al. have recently described the synthesis 
and expression of a GPllla analogue in cultured human en- 
dothelial cells (33). Interestingly, they could not detect the 
presence of a GPIIb-like molecule using any of the methods 
used in their study3 Since most of the functions ascribed to 
GPIIIa in human platelets require its calcium-dependent as- 
sociation with  GPI/b,  we  were interested in  investigating 
whether GPI/b is present in endothelial cells, and whether 
it is associated with GPIIIa, as it is in platelets. In this report, 
we use a combination of immunological, biochemical, and 
in vitro labeling techniques to address these questions. 
Materials and Methods 
Ce//s 
Human umbilical  vein  endothelial  cells  were  cultured  in complete  medium 
consisting of RPMI 1640 (Gibco  Laboratories,  Grand  Island, NY) contain- 
ing 20% fetal  calf serum, 5.9 g/liter Hepes, 2 mM L-glutamine, 100 U/mi 
penicillin, and 100 U/ml streptomycin,  using previously  described  methods 
(11) that are described  in detail  by McCarroll et al (18). Secondary  cultures 
were  prepared  by splitting  primary  cultures 1:3, and were  subcultured  in the 
2. For simplicity,  the terms "GPIIb"  and "GPIfia"  will be used in this  paper 
to describe  these and other analogues found on adhesive  cells other than 
platelets, with the caveat  that these  analogues may be structurally  and anti- 
genically similar, but not identical, to their platelet prototypes. 
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thelial cell proteins. 50 I~g of protein was separated on 7% poly- 
acrylamide slab gels and transferred to nitrocellulose. (A) Amido- 
Black-stained lanes. (B) Immunologically stained with rabbit poly- 
clonal anti-platelet GPIlb-IIIa antibody followed by peroxidase- 
conjugated goat anti-rabbit IgG. (C) Same as in B, but stained with 
normal rabbit serum.  Lanes 1  contain whole solubilized platelet 
proteins.  Lanes 2  contain whole solubilized endothelial cell pro- 
teins. Lanes 3 contain fresh endothelial cell growth medium con- 
taining 20%  horse serum.  Color development proceeded via the 
chromogenic peroxidase substrate, 4-chloro-l-naphthol. 
presence of 100 I~g/ml endothelial cell growth factor derived from bovine 
pituitaries (17). Total cellular protein was recovered by lysing washed,  cul- 
tured cells in situ in lysing buffer (0.1 M Tris, 38 mM glycine, 2 mM EDTA, 
2 mM N-ethylmaleimide,  2 mM iodoacetic acid, and 0.4 mM phenylmethyl- 
sulfonylfluoride  [pH 8.7]). Cell lysates were clarified  by centrifugation at 
15,000 g for 1.5 rain and stored  at -80°C until use. 
Human platelets were obtained by differential centrifugation of 10-50 ml 
samples of whole blood collected from volunteer donors at The Blood Cen- 
ter of Southeastern  Wisconsin.  Platelet lysates were prepared and stored ac- 
cording to the procedure outlined above for endothelial cells. 
Antibodies 
Polyclonal antiserum with specificity  for human platelet membrane GPIIb 
and GPIIIa was prepared in rabbits by twice-monthly intradermal injection 
of SDS-denatured  GPIlb-IIIa that had been purified using a previously  de- 
scribed Triton X-114  phase-extraction procedure (22). Purified IgG was ob- 
tained using a combination of ammonium sulfate fractionation and DEAE 
cellulose chromatography  using standard techniques.  The specificity of this 
preparation was confirmed by immunoprecipitation  of radioiodinated,  solu- 
bilized platelets,  by crossed immunoelectrophoresis vs. solubilized whole 
platelets,  and by Western-blot  analysis.  All three methods indicated that 
most of the antibodies reacted with GPHb and GPHIa, with minor reactivity 
against GPIV also present. FOr unknown reasons, reactivity with a 200,000- 
Mr protein was also occasionally observed. 
To investigate  the presence of GPIIIa in various preparations, a  well 
characterized murine monoclonal antibody,  AP3,  was used as a specific 
probe. The properties and purification of this antibody have been previously 
described in detail (23).  AP3 has specificity  for GPIHa both complexed to 
and dissociated  from GPHb,  reacts equally  well with both allelic forms of 
GPIHa, P1AI and P1 ^2, and binds SDS-solubilized  nonreduced GPIIIa that 
has been immobilized onto nitrocellulose. 
Electrophoresis and Immunoblotting 
All operations were performed at room temperature except where indicated. 
For Westeru-blot analysis, cell lysates were diluted 1:1 with a buffer contain- 
ing 4% SDS, 250 mM Tris,  20% glycerol  (pH 6.8), and electrophoresed 
through a 7 % polyacrylamide gel using the buffer system of Laemmli (16). 
After electrophoresis,  proteins were transferred at 4°C to nitrocellulose ac- 
cording to the method of Towbin (34).  Sample strips were stained  with 
Amido Black to verify efficient transfer of both large and small molecular 
weight proteins.  The remainder of the nitrocellulose was incubated with 
blocking buffer (3 % gelatin dissolved  in 500 mM NaC1 and 20 mM Tris, 
[pH 7.5]) for 30-60 min to block unreacted sites. Nitrocellulose  strips were 
then incubated for 18 h in blotting buffer (20 mM Tris, 500 mM NaCI and 
I% gelatin [pH 7.5]) containing  either polyclonal  or monoclonal antibody 
at a final concentration of 30 gg/ml. Strips were then washed twice for 10 
min each in blotting buffer, incubated with a 1:2,500 dilution of peroxidase- 
conjugated second antibody (BioRad Laboratories,  Richmond, CA) for 2 h, 
and finally washed an additional two times in blotting buffer. Immunoreac- 
tive zones were identified by treating the strips with the peroxidase substrate 
4-chloro-l-naphthol  (60 rag) dissolved in 20 ml methanol that was combined 
with 100 ml of 20 mM Tris, 500 mM NaC1 (pH 7.5), and 100 gl of 30% 
hydrogen  peroxide immediately  before use.  Dot-blotting  was performed 
similarly to Western-blotting,  except that cell lysates were applied directly 
to prewetted  nitrocellulose paper in the form of 1-gl droplets,  rather than 
transferred electropboretically.  We were routinely able to detect as little as 
100 10g of specific  antigen using this technique for both dot- or Western- 
blotting. 
Immunoprecipitation 
Endothelial cells were  metabolically  labeled by first  incubating washed 
confluent cultures with methionine-free RPMI 1640 for 2 h, followed by an 
additional hour in 10 ml of the same medium containing 250 gCi of [3sS]. 
methionine (New England Nuclear,  Boston, MA) (specific activity,  1,000 
Ci/mmol). After washing twice with RPMI 1640 containing 1 mg/mi cold 
methionine, the ceils were put back into culture for an additional 18 h in 
the presence of complete medium. Triton lysates were prepared as described 
above and precleared by a 30-rain incubation with normal rabbit IgG, fol- 
lowed by a 5-rain incubation with Protein A-Sepharose beads. The beads 
were removed by centrifugation and indirect immunoprecipitation analysis 
was performed on the superuatants  by incubating ~500,000 cpm of labeled 
protein with 2 gl (10 I~g) of specific antibody. The same amount of normal 
rabbit IgG was added to a duplicate tube to serve as a control. After a 2-h 
incubation, 100 gl of a 50% slurry of Protein A-Sepharose was added, and 
allowed to bind immune complexes  for an additional 30 rain. The beads 
were  washed  exhaustively  in a  buffer containing 50 mM Tris,  150 mM 
NaCI, I mg/ml methionine, 1% bovine serum albumin (BSA), and 0.1% SDS 
(pH 7.2),  and bound proteins eluted by boiling the beads in  150  ~ti of 
125 mM Tris, 2% SDS, and 10% glycerol (pH 6.8). Samples were analyzed 
by SDS-PAGE in 7 % polyacrylamide  slab gels,  followed by fluorography 
against Kodak XRP-I x-ray film for 5-30 d at -80°C.  Molecular weights 
were determined by comparison to known standards (BioRad Laboratories). 
Crossed Immunoelectrophoresis 
Crossed immunoelectrophoresis (CIE) was performed by mixing 100 I~g of 
Triton X-100-solubilized platelet  proteins with 500,000 cpm ("°5 pg protein) 
of [35S]methionine-labeled endothelial cell lysates and electrophoresing the 
mixture at 10 V/cm for 75 min at 16°C in 1% agarose dissolved in 38 mM 
"Iris, 100 mM glycine,  and 0.5%  Triton X-100 (pH 8.8). Strips of agarose 
containing the separated proteins were then run at 90  ° into a 7-cm gel con- 
taining rabbit anti-whole platelet antibody for an additional 18 h at 2 V/cm. 
Immunoprecipitin arcs were visualized  by staining with Coomassie Blue 
R-250. Radiolabeled  arcs were identified by exposing dried CIE plates that 
had been treated with Enhance Spray (New England Nuclear, Boston, MA) 
to Kodak XRP-1 film as described above, and comparing the resulting au- 
toradiographs  to the Coomassie-stained  plates. 
Results 
Identification of  Platelet Membrane GPIIb and GPIIIa 
Analogues in Endothelial Cells 
Human umbilical vein endothelial cells were maintained in 
culture for 3 wk and split 1:3 at the end of each week before 
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platelet contamination derived from blood during harvesting 
from the umbilical vein. Fig. 1 A shows the total lysate pro- 
tein  derived  from purified human platelets  (lane  1)  and 
twice-passaged human endothelium (lane 2) that has been 
resolved  on  a  7%  SDS  polyacrylamide slab  gel,  trans- 
ferred  to  nitrocellulose,  and  stained  with  Amido  Black. 
It is evident from these two lanes that very efficient trans- 
fer of both large (>250,000 D) and small (<10,000 D) pro- 
teins has occurred. Fig. 1 B represents an identical blot that 
has been immunologically stained with a  polyclonal anti- 
body raised against purified platelet membrane GPIIb and 
GPIIIa. Previous work of many investigators (6,  15,  19) has 
established that GPIIb  (nonreduced Mr,  136,000) is  com- 
posed of an a-chain (Mr, 125,000) that is disulfide-linked to 
a smaller 13-subunlt (Mr, 21,000). On the other hand, GPIIIa 
contains  numerous  intrachain disulfide bonds  that,  upon 
reduction,  result  in  an  increase  in  Mr  (nonreduced  Mr, 
90,000;  reduced Mr,  105,000).  As  shown in lane  1,  both 
platelet GPIlb and GPIIIa react strongly with the polyclonal 
rabbit antibody, as expected. Lane 2 contains an endothelial 
cell lysate, and shows that two proteins having similar or 
identical molecular masses to GPIIb and GPIIIa also stain 
with this antibody. Unlike its platelet counterpart, however, 
the GPIIIa-like molecule stained less intensively than the 
GPIIb analogue, and its mobility appeared to be consistently 
higher  than  platelet  GPIIIa,  though  only  slightly.  This 
differential staining intensity was not always observed, and 
might be due to spurious proteolysis of the GPIIIa analogue. 
Greater antigenic cross-reactivity between GPIIb and its en- 
dothelial cell analogue would also yield similar results. Two 
other as yet unidentified endothelial cell proteins were de- 
tected by Western blotting, having approximate molecular 
masses of ,~66,000  and 105,000 D. As a control for the pos- 
sible presence of cross-reactive equine platelet membrane 
fragments  in  the  horse  serum  used  in  culturing  the  en- 
dothelium, Complete Medium (see Materials and Methods) 
was analyzed for reactivity in lane 3.  As shown, only one 
band at  170,000 D was stained, probably corresponding to 
Figure 2. Western-blot  analysis 
of nonreduced platelet and en- 
dothelial cell lysates. (A) Immu- 
nologieally  stained  with  polyclo- 
nal rabbit anti-platelet GPIIb- 
II/a, as in Fig. 1 B. (B) Overlaid 
with 30 I~g/ml  of  the anti-plate- 
let GPllIa-specific monoclonal 
antibody,  AP3, followed  by per- 
oxidase-conjugated  rabbit anti- 
mouse IgG. P, lane containing 
50 ~tg whole platelet protein. E, 
lanes containing 50  Ixg endo- 
thelial cell lysate protein. The 
decreased mobility of the left- 
most portion of  the GPIIIa band 
in lane P  is due to partial di- 
sulfide-bond reduction resulting 
from its proximity to mercapto- 
ethanol-containing  samples (not 
shown) that were run adjacent 
to this lane. This shift in mobil- 
ity upon reduction is character- 
istic of GPIIIa (see Fig. 3). 
Figure 3.  Indirect immunoprecipitation of [3SS]methionine meta- 
bolically labeled endothelial cells. Confluent cell cultures were la- 
beled, lysed with Triton X-100, and preeleared by sequential addi- 
tion of normal rabbit IgG and Protein A-Sepharose. Precleared 
supernatants were then incubated with rabbit anti-platelet GPllb- 
IIla (lane 1) or normal rabbit IgG (lane 2). Immune complexes 
were recovered by a 30-min incubation with Protein A-Sepharose, 
eluted off the beads by boiling in an SDS-containing  solution (see 
Materials and Methods), and analyzed by SDS-PAGE and fluorog- 
raphy. Lane 3 contains •20,000  cpm of whole radiolabeled en- 
dothelial cell lysate. (A) Samples analyzed following  treatment with 
5 % 2-mercaptoethanol. (B) Identical samples as in A, but analyzed 
nonreduced. Arrows denote the positions, from top to bottom, of 
EC GPIIb and EC GPIIIa, respectively. Molecular mass markers 
are shown at right in kilodaltons. 
horse IgG that cross-reacted with the peroxidase-conjugated 
anti-rabbit IgG second antibody reagent used in the detec- 
tion of immune complexes on the nitrocellulose paper. 
To  confirm  and  extend  these  results,  platelet  and  en- 
dothelial cell lysates were subjected to further Western-blot 
analysis  using  the  GPIIIa-specific  monoclonal  antibody, 
AP3, as a specific probe. As Fig. 2 shows, AP3 reacted with 
a single endothelial cell protein that was nearly identical in 
molecular weight to platelet GPHIa, further supporting the 
relationship between these two proteins. Based upon the re- 
suits shown in Figs. 1 and 2, we adopted the convention sug- 
gested by Thiagarajan et al. (33) to term the endothelial cell 
analogue of platelet GPIIb-IIIa, EC GPIIb, and EC GPffla, 
respectively. 
Metabolic Labeling of  EC GPIIb and EC GPIII 
To demonstrate that these two molecules were actively being 
synthesized by cultured endothelium, cells were cultured in 
the presence of [35S]methionine,  lysates prepared,  and in- 
direct  immunoprecipitation  analysis  performed.  Fig.  3 
shows the results of one such experiment. Fig. 3 A shows 
preparations analyzed under reducing conditions, while Fig. 
3 B shows the same samples analyzed under nonreducing 
conditions. When total radiolabeled lysate proteins (lane 3) 
were incubated with rabbit anti-platelet GPl/b-Illa antibody, 
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precipitated (lane 1), Normal rabbit IgG did not react at all 
with these two proteins (lane 2). 
Crossed Immunoelectrophoresis 
To explore the possibility that EC GPIIb and EC GPI/Ia exist 
in a complex after solubilization in Triton X-100, and to fur- 
ther explore the structural and immunological relationship 
between these two proteins and their platelet analogues, un- 
labeled  platelet  lysates were  mixed  with  [35S]methionlne 
metabolically labeled endothelial cell lysates in the presence 
of excess cold methionine, and the mixture analyzed by CIE 
using a rabbit anti-whole platelet antibody preparation in the 
second dimension. As Fig. 4 A shows, Coomassie Blue stain- 
ing revealed the presence of a major precipitin arc that has 
been  shown to contain the calcium-dependent GPIIb-lIIa 
complex (14). It has been previously shown that chelation of 
calcium results in dissociation of the complex, disappear- 
ance of the GPRb-RIa arc, and the concomitant appearance 
of two new precipitin arcs containing the individual glyco- 
proteins (8, 14). Thus, the appearance in the corresponding 
autoradiograph (Fig. 4 B) of  a single precipitin arc that is vir- 
tually superimposable with the platelet GPI/b-IRa complex 
strongly indicates that EC GPIlb and EC GPRIa exist com- 
plexed in  Triton lysates of human endothelium.  Further- 
more, when endothelial cell lysates were analyzed by CIE 
without  prior  admixture  with  solubilized  platelets  (not 
shown) the precipitin arc formed by the GPllb-lIIa complex 
was still prominent, though it represented only 5-10% of the 
area given by the corresponding arc shown in Fig. 4, reflect- 
ing the proportionately decreased amount of this glycopro- 
tein complex in endothelial ceils relative to that found in 
platelets. 
Discussion 
Human endothelial cells have previously been shown to syn- 
thesize several proteins that are also present in circulating 
blood platelets, including yon Willebrand factor (9, 36), yon 
Willebrand Antigen U (18), thrombospondin (21, 28),  and 
fibronectin (10). In this paper, we have shown that endothelial 
cells also synthesize a protein that is both structurally and 
immunologically related to platelet membrane GPIlb, and 
have confirmed an earlier report (33) that they synthesize its 
membrane counterpart, GPIIIa. Moreover, we have provided 
evidence that these two membrane glycoproteins exist com- 
plexed to each other after solubilization in Triton X-100, as 
is the case for GPllb-IIIa in human platelets. 
Using a polyclonal antibody with specificity for denatured 
GPIIb and GPIIIa allowed us to detect the presence of ana- 
logues of both of  these two platelet membrane glycoproteins. 
In contrast, Thiagarajan et al. (33) used both a monoclonal 
and a polyclonal antibody, each having specificity for only 
GPUIa,  to  detect  a  related  protein  in  endothelial  ceils. 
Though these authors suggested that a GPl/b-like molecule 
was unlikely to be present in cultured endothelium, their ar- 
gument was in part based upon their unpublished observa- 
tions that the anti-platelet GPllb-specific monoclonal anti- 
body, Tab (19, 20), was unreactive with endothelial cells. It 
is possible, however,  that the epitope on GPI/b defined by 
Tab has not been conserved in its endothelial cell analogue. 
Since GPI/b is a large glycoprotein (mol mass, 136,000), it 
is likely that several regions on the molecule could be subtly 
modified without significantly altering its overall structure 
and function. 
Support for the presence of a complex between EC GPI/b 
and EC GPRIa was generated by our finding a metabolical- 
ly labeled precipitin arc derived from endothelium that mi- 
Figure 4. CIE of a mixture of 
platelet  and  endothelial cell 
proteins. 100 nag of unlabeled 
platelet  lysate  protein was 
mixed with 500,000 cpm ('~5 
ttg) of [35S]methionin~labeled 
endothelial cell  protein, and 
the mixture separated by CIE 
into an agarose gel containing 
polyclonal rabbit  anti-whole 
platelet antibody. (A) The re- 
suiting CIE plate stained with 
Coomassie Blue. (B) The flu- 
orograph derived by exposure 
of the CIE plate. The arrow 
denotes the  major precipitin 
arc formed by the GPllb-llIa 
complex.  Note  that  several 
Coomassie-stained  arcs are 
not  radiolabeled, and  vice 
versa. 
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CIE gels (Fig. 4). By mixing together the two samples, one 
labeled and the other not, before their two-dimensional sepa- 
ration based upon first size and charge,  and then upon im- 
munologic cross-reactivity,  we were able to demonstrate ho- 
mology between the precipitin arcs given by the platelet and 
endothelial  cell IIb and IIIa. Further studies are necessary 
to determine the precise structural and physical requirements 
for IIb-lIIa complex formation  in these two cell types. 
GPIlb/IIIa-like  molecules  have  now  been  identified  in 
several varied cell types (7, 15, 32, 33). Moreover, while this 
paper was in review, a Communication appeared (5) indicat- 
ing that human endothelial cells synthesize two glycoproteins 
similar to platelet GPIIb and GPIIIa, thereby independently 
confirming the results presented in this paper. Since the pri- 
mary role of the GPllb-l/Ia complex in platelets is mediating 
platelet aggregation through its fibrinogen-receptor  activity, 
it is reasonable to wonder what the possible role of an analo- 
gous receptor might be in human transformed cell lines (7, 
32),  or on the supposedly hemostatically  inert endothelial 
cell surface  (5, 33, this paper).  While we do not yet know, 
we  might  speculate  that  this  large  heterodimer  complex 
could support several varied functions, of which only several 
might play a role in any given cell type. Brass and Shattil (4), 
and Brass (3) have shown that GPffb and GPIIIa represent 
the  major  Ca+e-binding  surface  glycoproteins  in  resting 
platelets,  and may play  a  role in Ca  ÷2 transport.  Perhaps 
they have similar functions in other cell types.  Shadle et al. 
(31) recently demonstrated that GPI/b plays a role in the ad- 
herence of platelets to collagen. It is, therefore, possible that 
its analogue might play an important role in mediating  the 
normal attachment of endothelial  cells to the collagen-rich 
subendothelial  matrix of the vascular wall. 
Preliminary results obtained in our laboratory indicate that 
EC GPRIa also bears the human platelet  alloantigen,  P1 At 
(12) (to be published in detail elsewhere). Since the P1  A1 an- 
tigenic determinant has recently been localized to a 17-kD re- 
gion of GPIIIa (24), these results provide further support for 
the homology shared by GPIIIa and EC GPHIa.  Further- 
more, this finding might have important implications regard- 
ing  the  etiology  of such  alloimmunological  disorders  as 
posttransfusion purpura, neonatal alloimmune thrombocyto- 
penia, and autoimmune thrombocytopenia,  where antibodies 
directed against either GPIlb or GPIIIa, or both, mediate the 
immune destruction  of circulating  platelets.  Studies are in 
progress  to further investigate  this question. 
We have found that EC GPIIb and EC GPIIIa continue to 
be synthesized by cultured endothelium for at least eight pas- 
sages (2 mo) (data not shown). Long-term maintenance  of 
endothelial  ceils  in culture  allows large  numbers  of these 
cells to be grown and harvested,  raising  the possibility of 
preparing cDNA libraries  that would contain genes coding 
for  EC GPHb  and EC GPIIIa.  Eventual  cloning of these 
specific genes should allow for their comparison with similar 
proteins  found in platelets  and other cells,  and could yield 
important  clues  regarding  the  structural requirements  for 
their function(s) in these varied cell types. 
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